- Home
- AUPH vs SGRY Comparison
AUPH vs SGRY Comparison
Compare AUPH & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | SGRY |
|---|---|---|
| Founded | 1993 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | AUPH | SGRY |
|---|---|---|
| Price | $15.60 | $12.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $17.25 | ★ $22.25 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | 54.14 |
| EPS | ★ 2.07 | N/A |
| Revenue | $283,055,000.00 | ★ $1,145,438,000.00 |
| Revenue This Year | $16.53 | $5.09 |
| Revenue Next Year | $16.24 | $5.67 |
| P/E Ratio | $7.48 | ★ N/A |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $6.83 | $11.41 |
| 52 Week High | $16.54 | $24.10 |
Technical Indicators
Market Signals| Indicator | AUPH | SGRY |
|---|---|---|
| Relative Strength Index (RSI) | 63.33 | 39.76 |
| Support Level | $14.56 | $11.61 |
| Resistance Level | $16.28 | $16.15 |
| Average True Range (ATR) | 0.52 | 0.46 |
| MACD | 0.15 | 0.08 |
| Stochastic Oscillator | 99.72 | 48.54 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.